Karen Ersche’s work focuses on the neurochemical processes underlying addictive behavior and how to translate these findings into therapies. Her findings have contributed to new behavioral and pharmacological approaches. For this work, she was awarded the Jacob P. Waletzky Award in 2017.
What led you to study drug addiction, particularly cocaine addiction?
My enthusiasm for drug addiction research is rooted in the potential it has to make a difference in people’s lives. Scientific advances have fundamentally changed the understanding of addiction from a deficit of character to a brain disorder, and I strongly believe it will also provide the pathway for developing more effective treatments.
My research aims to tackle the problems surrounding cocaine addiction, which is a fairly common disorder in the United Kingdom with few effective treatments.
Access to the full article is available to SfN members.
Neuronline is a benefit of SfN membership. Renew your membership now to make sure you don’t lose access.
Log In Join SfN
Speaker
Karen Ersche, PhD
Karen D. Ersche is an associate professor at the University of Cambridge, a member of the Behavioral and Clinical Neuroscience Institute, and an Official Fellow at Clare Hall College in Cambridge. Her field of interest and expertise lies in human drug addiction. Ersche carried out research as a Betty Behrens Fellow prior to being appointed to a lectureship at the University of Cambridge in 2014. She advocates for issues of drug addiction as a member of the Scientific Advisory panel to the European College for Psychopharmacology. Her research combines a variety of different approaches and collaborations with other disciplines to assess a broad range of effects of drug abuse on individuals’ health and wellbeing. Ultimately, Ersche’s goal is to enhance progress of addiction recovery by developing more effective treatments and reducing the widespread stigma attached to the disorder. She holds an MA in psychology from the University of Konstanz, a MSc from the University of Exeter, and a PhD from the University of Cambridge.